Supernus Pharmaceuticals (SUPN) PT Raised to $40 at Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts SUPN Hot Sheet
Price: $41.92 --0%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 13
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 13
Join SI Premium – FREE
Cowen analyst Ken Cacciatore raised the price target on Supernus Pharmaceuticals (NASDAQ: SUPN) to $40.00 (from $35.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Supernus Pharma (SUPN) Misses Q3 EPS by 21c
- InterGlobe Aviation Ltd. (INDIGO:IN) PT Raised to INR6,200 at Nomura/Instinet
- Kia Motors (000270:KS) (KIMTF) PT Lowered to KRW150,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
